Hyperglycemia in Critically Ill Patients
Conditions
Keywords
intensive insulin therapy, glucose control, nurse directed, nomogram directed
Brief summary
There is current evidence that maintaining ICU patient's blood sugar between 4.4-6.1 saves lives. However, this is difficult to do in the ICU and carries risks of lowering the blood sugar too much. In addition, the best way to achieve this control is not known. Many strict nomograms that provide a standardized approach for nurses have been developed and validated, including one here at SMH. However, these nomograms cannot apply to all patients at all times, especially ICU patients whose needs are rapidly changing. ICU nurses are at the bedside constantly, are very familiar with their patient's needs, and have decades of experience in titrating medication doses without a nomogram to achieve a pre-determined response (i.e. medications to achieve pre-selected blood pressure). Indeed, once the bedside nurse has bought into the importance of the concept of tight glucose control and have been introduced to the nomogram here at SMH, their experience and intuition may be more adaptable to the changing needs of the patient than an inflexible paper nomogram. This study will compare glucose control using our current standard nomogram versus no nomogram (i.e. nurse directed) in order to determine whether the nomogram should continue to be used.
Interventions
Based on the nursing judgement, titrate insulin infusion and determine glucose check frequency to achieve a target glucose of 5-8 mmol/L
A preprinted order outlining a nomogram with instructions for how insulin infusion should be changed based on measured glucose values and how frequent the glucose checks should be
Sponsors
Study design
Eligibility
Inclusion criteria
Patients: * adult CVICU pts * requires insulin therapy for glucose greater than 8 mmol/L * anticipated ICU stay \> 24 hrs * not in DKA/HHNK * mechanically ventilated
Exclusion criteria
* MD refusal * no IV access for insulin * allergy to insulin * DNR or moribund as determined by the clinical team
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean area-under-the curve for blood glucose within target per shift | over 12 hours |
Secondary
| Measure | Time frame |
|---|---|
| Hypoglycemia frequency | per shift |
Countries
Canada